Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Mira PharmaceuticalsMIRA | Open-market sale10b5-1 plan | 24/11/19–24/11/20 | 24/11/27 | 100,000 sh2 trades | $1.34avg. | $133,649.2 | −8.6% | |
Bay Shore Trust10% Owner | Mira PharmaceuticalsMIRA | Open-market sale | 24/08/28 | 24/08/30 | 200,000 sh | $1.96 | $392,000 | −7.3% |
Brian Patrick McNulty10% Owner | Mira PharmaceuticalsMIRA | Open-market sale | 24/08/28 | 24/08/30 | 200,000 sh | $1.96 | $392,000 | −7.3% |
Mira PharmaceuticalsMIRA | Open-market buy | 24/05/21 | 24/05/22 | 8,700 sh8 trades | $0.94avg. | $8,176 | +2.3% | |
Mira PharmaceuticalsMIRA | Open-market sale | 23/11/20–23/12/11 | 23/12/27 | 238,095 sh22 trades | $3.05avg. | $725,794.85 | −26.5% | |
Mira PharmaceuticalsMIRA | Open-market sale | 23/11/20–23/12/11 | 23/12/27 | 238,095 sh22 trades | $3.05avg. | $725,794.85 | −26.5% | |
George Cappy10% Owner | Mira PharmaceuticalsMIRA | Open-market buy | 23/08/07 | 23/08/24 | 119,048 sh | $7.00 | $833,336 | +4.3% |
Bay Shore Trust10% Owner | Mira PharmaceuticalsMIRA | Open-market buy | 23/08/07 | 23/08/24 | 119,048 sh | $7.00 | $833,336 | +4.3% |
George Cappy10% Owner | Mira PharmaceuticalsMIRA | Open-market buy | 23/08/02 | 23/08/04 | 157,170 sh | $7.00 | $1,100,190 | +6.1% |
Bay Shore Trust10% Owner | Mira PharmaceuticalsMIRA | Open-market buy | 23/08/02 | 23/08/04 | 157,170 sh | $7.00 | $1,100,190 | +6.1% |